Shelley Kalsi, M.D.

Dr. Shelley Kalsi is Director of the Hematology Consult Service, Division of Intramural Research, at the National Heart, Lung, Blood Institute. She earned her medical degree at the Feinberg School of Medicine, Northwestern University, as part of the Honors Program in Medical Education. She completed Residency in Internal Medicine at the University of Maryland and Fellowship in Hematology/Oncology at the University of Pittsburgh. She completed Fellowship in Transfusion Medicine/Blood Banking at the National Institutes of Health, after which she joined the NHLBI. In her current role, she oversees the hematology consult program at NIH, participates in trainee education, and participates in hematologic research that supports protocols across the NIH Intramural program. She has authored and co-authored multiple peer-reviewed journal articles on various topics in Transfusion Medicine and hematology.

Publications

Granulocyte transfusions in severe aplastic anemia

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers

Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation

Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome

Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics